Gainers
• Genprex, Inc. (NASDAQ:GNPX) stock increased by 18.3% to $1.36 during Tuesday’s after-market session.
• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares rose 7.8% to $3.16. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.
• Menlo Therapeutics, Inc. (NASDAQ:MNLO) stock rose 7.4% to $6.93.
• Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stock increased by 7.4% to $0.58.
• KemPharm, Inc. (NASDAQ:KMPH) stock increased by 7.0% to $0.44. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.
• Viking Therapeutics, Inc. (NASDAQ:VKTX) shares rose 5.5% to $7.48.
• Athersys, Inc. (NASDAQ:ATHX) stock increased by 4.7% to $1.34.
• Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares moved upwards by 4.4% to $0.39.
• Foamix Pharmaceuticals, Inc. (NASDAQ:FOMX) stock surged 4.3% to $4.82.
• Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) stock rose 3.7% to $2.23.
• Oncolytics Biotech, Inc. (NASDAQ:ONCY) stock moved upwards by 3.7% to $3.68.
• Trillium Therapeutics, Inc. (NASDAQ:TRIL) stock increased by 3.6% to $2.87.
• Aduro Biotech, Inc. (NASDAQ:ADRO) stock increased by 3.5% to $1.46. According to the most recent rating by Cowen & Co., on January 10, the current rating is at Market Perform.
• Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) shares surged 3.3% to $0.20.
• Intrexon, Inc. (NASDAQ:XON) shares moved upwards by 3.1% to $5.80.
• Intec Pharma, Inc. (NASDAQ:NTEC) stock rose 3.0% to $0.58.
Losers
• Novavax, Inc. (NASDAQ:NVAX) stock plummeted 10.7% to $8.77 during Tuesday’s after-market session.
• Sophiris Bio, Inc. (NASDAQ:SPHS) stock decreased by 8.3% to $0.80.
• Adaptimmune Therapeutics, Inc. (NASDAQ:ADAP) stock declined 5.3% to $3.92.
• DBV Technologies, Inc. (NASDAQ:DBVT) stock decreased by 3.6% to $12.00. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.
